Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
PDSB
#3621
PDS Biotechnology Corporation Common Stock
0.6
8
-1.45%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.45%
Variazione Mensile
-32.00%
Variazione di 6 mesi
-47.29%
Variazione Annuale
-52.45%
Chiusura Precedente
0.6
9
Open
0.6
8
Bid
Ask
Low
0.6
8
High
0.6
8
Volume
6
Mercati
Mercato Azionario Statunitense
Salute
PDSB
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Notizie
PDS Biotech amends Phase 3 trial to add accelerated approval path
PDS Biotechが前立腺がん研究で9.6ヶ月の無増悪生存期間を報告
PDS Biotech reports 9.6-month progression-free survival in prostate cancer study
PDSバイオテック、がん免疫療法PDS0101の特許を取得
PDS Biotech secures patent for cancer immunotherapy PDS0101
PDS Biotechの株価、FDAとの会議で迅速承認への道が開け急上昇
PDS Biotech stock soars after FDA meeting provides accelerated approval path
PDSバイオテック、第3相がん治験の改訂プロトコルを提出
PDS Biotech submits amended protocol for phase 3 cancer trial
PDS Biotech secures new patent for cancer immunotherapy in Japan
PDS Biotechnology (PDSB) Upgraded to Buy: Here's Why
PDSバイオテク、迅速承認経路の協議のためFDA会議を確保